FDA approves Nucala for Eosinophilic Granulomatosis with Polyangiitis
The FDA has expanded the approved use of Nucala to treat a rare autoimmune disease that causes vasculitis, an inflammation of the wall of blood vessels of the body...
List view / Grid view
The FDA has expanded the approved use of Nucala to treat a rare autoimmune disease that causes vasculitis, an inflammation of the wall of blood vessels of the body...
The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union...
Two of the key organisations in the UK and Russia leading efforts to combat the global problem of antimicrobial resistance (AMR) have announced a formal agreement to work together.
Researchers have developed a biosensor that can detect diseased exosomes, important indicators of various health conditions...
Researchers believe they have a way to create the structural framework for growing living tissue using an off-the-shelf 3-D printer...
Drug molecule in tapeworm medicine activates protein implicated in the development of Parkinson's disease...
Light-emitting nanoprobes can detect cancer early and track the spread of tiny tumours...
The FDA has approved Admelog, a short-acting insulin indicated to improve control in blood sugar levels in diabetes...
Researchers have shown that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks of cholera...
A drug used to treat rheumatoid arthritis improves survival after hematopoietic stem cell transplant...
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and consequently found a compound that stops the disease in its tracks.
In a bid to maximise the effectiveness of treatment for patients, doctors have been using predictive models. New research finds that accessing data from electronic medical records could greatly benefit this practice.
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder...
New tests to detect early Lyme disease - which is increasing beyond the summer months - could replace existing tests that often do not clearly identify the infection before health problems occur.
Researchers have identified a type of human leukocyte antigen (HLA) that is associated with the skin disease bullous pemphigoid (BP) in diabetic patients administered with DPP-4 inhibitory drugs.